Mutual of America Capital Management LLC Trims Stock Holdings in Encompass Health Corporation (NYSE:EHC)

Key Points

• Mutual of America Capital Management LLC reduced its stake in Encompass Health Corporation by 5.7% in the 1st quarter, owning 59,090 shares worth approximately $5.98 million after selling 3,595 shares.
• Analysts have recently raised their price targets for Encompass Health, with Truist Financial setting a new price objective of $135.00 and UBS Group increasing it to $140.00, reflecting a consensus rating of "Buy" with an average target price of $133.17.
• Encompass Health announced a quarterly dividend increase to $0.19, payable on October 15th, representing a 0.7% yield, and a payout ratio of 13.31%.

Mutual of America Capital Management LLC trimmed its stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 5.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 59,090 shares of the company's stock after selling 3,595 shares during the period. Mutual of America Capital Management LLC owned about 0.06% of Encompass Health worth $5,985,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of EHC. LPL Financial LLC grew its stake in shares of Encompass Health by 8.8% during the 4th quarter. LPL Financial LLC now owns 35,558 shares of the company's stock worth $3,284,000 after purchasing an additional 2,869 shares during the period. Russell Investments Group Ltd. boosted its holdings in Encompass Health by 31.5% during the fourth quarter. Russell Investments Group Ltd. now owns 227,643 shares of the company's stock worth $21,023,000 after buying an additional 54,536 shares in the last quarter. Federated Hermes Inc. boosted its holdings in Encompass Health by 13.7% during the fourth quarter. Federated Hermes Inc. now owns 11,318 shares of the company's stock worth $1,045,000 after buying an additional 1,367 shares in the last quarter. FMR LLC grew its position in Encompass Health by 0.8% during the fourth quarter. FMR LLC now owns 1,973,846 shares of the company's stock valued at $182,285,000 after buying an additional 15,831 shares during the period. Finally, Cerity Partners LLC increased its holdings in Encompass Health by 76.9% in the fourth quarter. Cerity Partners LLC now owns 5,837 shares of the company's stock valued at $547,000 after buying an additional 2,537 shares in the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Price Performance

EHC stock traded up $0.91 during midday trading on Friday, reaching $117.42. The stock had a trading volume of 780,635 shares, compared to its average volume of 1,204,908. Encompass Health Corporation has a 52-week low of $85.55 and a 52-week high of $123.13. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76. The company's fifty day simple moving average is $116.36 and its 200 day simple moving average is $108.66. The company has a market cap of $11.83 billion, a price-to-earnings ratio of 22.98, a price-to-earnings-growth ratio of 2.03 and a beta of 0.86.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, topping analysts' consensus estimates of $1.20 by $0.20. The firm had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. Encompass Health's quarterly revenue was up 12.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.11 earnings per share. As a group, sell-side analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a $0.19 dividend. This is a boost from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. Encompass Health's dividend payout ratio is 13.31%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Truist Financial reissued a "buy" rating and set a $135.00 target price (up from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. UBS Group upped their price target on Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a report on Wednesday. Royal Bank Of Canada raised their price objective on Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a report on Monday, April 28th. Wall Street Zen cut Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. Finally, Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 target price on the stock in a research report on Thursday, June 5th. Seven research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Encompass Health presently has an average rating of "Buy" and a consensus price target of $133.17.

Insider Activity at Encompass Health

In other news, CEO Mark J. Tarr sold 118,384 shares of the business's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the transaction, the chief executive officer owned 527,070 shares of the company's stock, valued at approximately $64,054,817.10. The trade was a 18.34% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.00% of the stock is currently owned by corporate insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.